Skip to main content
. 2016 Apr 7;2016:3918219. doi: 10.1155/2016/3918219

Table 3.

Effect of Tamarindus indica L. tablets on serum biochemical markers of liver function in CCl4 induced hepatotoxicity in Sprague Dawley rats.

Group ALT (UI/L) AST (UI/L) ALP (UI/L) GGT (UI/L) TB (mg/100 mL) TP (g/100 mL)
I 32.56 ± 2.05b 21.37 ± 0.59c 187.32 ± 3.08d 86.18 ± 3.86d 3.09 ± 0.04d 7.12 ± 0.47b
II 326.78 ± 19.31a 95.97 ± 4.41a 426.53 ± 3.31a 161.30 ± 7.90a 6.57 ± 0.09a 5.26 ± 0.37c
III 36.33 ± 0.94b 37.27 ± 5.64b 204.56 ± 2.90c 98.10 ± 1.40c 4.84 ± 0.25c 8.29 ± 0.22a
IV 38.62 ± 0.98b 38.67 ± 2.50b 246.76 ± 3.10b 111.10 ± 1.19b 5.21 ± 0.17b 7.41 ± 0.23b
V 33.49 ± 0.91b 25.38 ± 2.38c 202.51 ± 4.96c 99.09 ± 3.34c 5.15 ± 0.06b 8.33 ± 0.34a

ALT: alanine aminotransferase, AST: aspartate aminotransferase, ALP: alkaline phosphatase, GGT: γ-glutamyl transpeptidase, TB: total bilirubin, and TP: total protein.

I: control group; II: CCl4 induced hepatotoxicity group; III: Silymarin treated group; IV and V: Tamarindus indica L. tablets treated groups at doses 100 mg/kg and 200 mg/kg, respectively.

Different letters on columns indicate significant statistical differences in Tukey HSD test.

Data are expressed as mean ± SD; n = 7.